Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease colorectal cancer
Symptom C0494165|liver metastases
Sentences 103
PubMedID- 20977728 Conclusions: although limited by small case number, this study demonstrated a possible role of whole-liver rt in improving hepatic dysfunction and delaying mortality from hepatic failure for end-stage colorectal cancer patients with massive liver metastases.
PubMedID- 23203441 Case no.1: a 67-year-old caucasian male was diagnosed of colorectal cancer with liver metastases without severe cardiovascular disease in history.
PubMedID- 25081377 Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases.
PubMedID- 26056460 The process of liver regeneration and tumor recurrence after partial hepatectomy performed in colorectal cancer patients with liver metastases is associated with an increase in the intrahepatic levels of ace in mouse models.
PubMedID- 24800922 Folfiri and sunitinib as first-line treatment in metastatic colorectal cancer patients with liver metastases--a cesar phase ii study including pharmacokinetic, biomarker, and imaging data.
PubMedID- 23876227 An elevated nlr in colorectal cancer patients with liver metastases receiving only neoadjuvant chemotherapy before surgical resection of liver metastases predicted worse rate of survival .
PubMedID- 24755295 In this study, mirna profiles between five colorectal cancer tissues with synchronous liver metastases and five colorectal cancer tissues without liver metastases were compared.
PubMedID- 23035809 Conclusions: laparoscopic liver resection is a safe and effective treatment for liver metastases in patients with colorectal cancer.
PubMedID- 23022595 Adc increases correlated with response to systemic chemotherapy in all studies with liver metastases of breast and colorectal cancer.
PubMedID- 22242554 Traditionally, resection of the primary tumor has been advocated in order to prevent complications of the primary tumor colorectal cancer in patients with synchronous liver metastases.
PubMedID- 24742404 colorectal cancer with liver metastases -- is there a chance for cure.
PubMedID- 20154497 Such a strategic multidisciplinary treatment can lead to a better prognosis for colorectal cancer with liver metastases.
PubMedID- 23700570 Chemotherapeutic agents, administration methods, and novel biological agents for the treatments of colorectal cancer with liver metastases allowed surgery to be performed even for initially unresectable metastatic lesions.
PubMedID- 23815814 In colorectal cancer with early liver metastases, co-expression of cd133 and cd44 is significantly higher when compared to those without early liver metastases .
PubMedID- 24267032 Nine male patients with liver metastases of colorectal cancer were included retrospectively (age, 48 to 76 years (mean 62.8); weight, 73 to 100 kg (mean 85.5)).
PubMedID- 24081807 Cause of death from liver metastases in colorectal cancer.
PubMedID- 25469725 Ten colorectal cancer patients with liver metastases received between one and five doses of oncolytic reovirus prior to surgical resection of their tumour.
PubMedID- 25297902 Is liver transplantation an option in colorectal cancer patients with nonresectable liver metastases and progression on all lines of standard chemotherapy.
PubMedID- 22560316 Study design: we conducted a retrospective cohort study of consecutive colorectal cancer patients with resectable synchronous liver metastases treated between 1993 and 2010, constructing a decision tree comparing simultaneous and staged resections.
PubMedID- 24394015 As the present case is considered rare, we herein review our previous report on a case of early colorectal cancer with synchronous multiple liver metastases.
PubMedID- 26452624 Haic was effective in some systemic chemotherapy-resistant colorectal cancers with liver metastases and should be considered as an effective palliative therapy.
PubMedID- 22811880 The management of colorectal cancer patients with liver metastases is a common clinical problem.
PubMedID- 20841952 Both were advanced colorectal cancer cases with liver metastases, so we started chemotherapy with modified folfox6+bevacizumab.
PubMedID- 25580640 Cxcr2, cxcr4, and their chemokine ligands were evaluated in liver metastases of colorectal cancer in order to study their correlation with overall and disease-free survival of patients having received, or not received, a neoadjuvant chemotherapy regimen.
PubMedID- 25666309 liver metastases in colorectal cancer patients decreases the expected 5 year survival rates by a factor close to nine.
PubMedID- 25465375 Background: a phase ii clinical trial was conducted on colorectal cancer patients with only liver metastases (focal diameter exceeds 5 cm or the number of liver metastases is >/=5; h2.h3) to evaluate the liver resection rate and safety after 6 cycles of mfolfox6+bevacizumab (bv) therapy.
PubMedID- 22962603 Firstly, we validated the suppression of mir-214 in human hcc by real-time quantitative rt-pcr (qrt-pcr) in 20 paired tumor and non-tumor liver tissues of hcc patients and 10 histologically normal liver tissues from colorectal cancer patients with liver metastases.
PubMedID- 21764578 Results: cd133 and cd44 were significantly higher co-expressed in colorectal cancer with early liver metastases compared to those without early liver metastases, and the content of cd133 and cd44 proteins decreased following growth of the transplanted tumors.
PubMedID- 25596059 Although the first-line treatment for liver metastases arising from colorectal cancer is surgery, it is unknown whether this treatment is equally effective for liver metastases with peritoneal dissemination.
PubMedID- 20544397 Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases.
PubMedID- 22202333 In this study, we retrospectively analyzed the efficacy of mfolfox6 in colorectal cancer patients with synchronous unresectable liver metastases and compared the prognosis between before and after the administration of mfolfox6.
PubMedID- 23075717 Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
PubMedID- 19508508 Method: a total of 168 patients who had been treated colorectal cancer with synchronous liver metastases at guangxi medical university from january 2000 to december 2005 were identified.
PubMedID- 25089107 Methods: colorectal cancer patients with liver metastases resected at the ottawa hospital between january 1, 2003, and december 31, 2009, were identified, and their clinical records were retrospectively reviewed.
PubMedID- 20617435 In a study in colorectal cancer patients with liver metastases, the liver metastases in 9 of 12 patients were visualized with 111in-bevacizumab (fig.
PubMedID- 20412096 Aim: this study compared the sensitivity and specificity of contrast-enhanced ultrasound (ceus) and multidetector-computed tomography (mdct) in the detection of liver metastases in patients with colorectal cancer.
PubMedID- 23010733 colorectal cancer with synchronous resectable liver metastases: monocentric management in a hepatobiliary referral center improves survival outcomes.
PubMedID- 20821329 This work investigated 5fu pharmacokinetics in liver metastases of colorectal cancer.
PubMedID- 25253940 colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone.
PubMedID- 20649733 Objective: to evaluate the effect of prophylactic regional liver chemotherapy during the perioperative period on improving survival and preventing liver metastases in patients with colorectal cancer (crc).
PubMedID- 23927554 Extensive experience with the technique has been gained in patients with isolated liver metastases of colorectal cancer (crc).
PubMedID- 23047645 Hmgb1 is a valuable serum biomarker for early estimation of therapy response and prognosis in colorectal cancer patients with liver metastases undergoing re therapy.
PubMedID- 25992208 Although surgery is the most effective treatment for liver metastases in colorectal cancer patients, only 15-20% of these patients are suitable for a radical surgical approach, and metastases recurrence may occur at follow up.
PubMedID- 20110289 Patients and methods: colorectal cancer patients with isolated liver metastases, who underwent ihp, were included in this study.
PubMedID- 26222850 Secondly, previous studies on colorectal cancer with liver metastases indicated that patients with extra hepatic metastases had poor survival,16,17 and some patients with extra hepatic metastases were included in the current study.
PubMedID- 22409860 One hundred and twenty cases of primary colorectal cancer with the corresponding liver metastases were analyzed in this study (70 men and 50 women; median age, 63.5 (range, 32- 91).
PubMedID- 22993665 Treatment strategy for colorectal cancer with resectable synchronous liver metastases: is any evidence-based strategy possible.
PubMedID- 23497123 We compared three groups, composed of 17 colorectal cancer patients with liver metastases who had undergone at least segmental anatomical hepatic resection (8 patients with and 9 patients without preoperative chemotherapy) and 15 patients in a living liver donor transplantation group in our department since january 2008. the preoperative chemotherapy regimen was oxaliplatin-based in six subjects, irinotecan-based in one subject, and oxaliplatin- and irinotecan-based in one subject.
PubMedID- 23611316 The cost-effectiveness of ceus was modelled separately for the three main clinical applications considered characterisation of flls detected on ultrasound surveillance of cirrhosis patients, detection of liver metastases in patients with colorectal cancer (crc), characterisation of incidentally detected flls.
PubMedID- 22874690 Background: the laparoscopic resection of colorectal cancer (crc) along with synchronous liver metastases has been attempted and reported in multiple single series.

Page: 1 2 3